Research programme: carbon monoxide releasing molecules - ALFAMA

Drug Profile

Research programme: carbon monoxide releasing molecules - ALFAMA

Alternative Names: ALF 421; CORM-A1; CORMs - ALFAMA

Latest Information Update: 14 Mar 2011

Price : $50

At a glance

  • Originator ALFAMA
  • Class Aldehydes; Carbonates; Organometallic compounds; Small molecules
  • Mechanism of Action Tumour necrosis factor inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Preclinical Inflammation; Multiple sclerosis; Rheumatoid arthritis

Most Recent Events

  • 11 Mar 2011 Preclinical trials in Multiple sclerosis in Portugal (unspecified route)
  • 07 Mar 2011 Preclinical development is ongoing in Portugal
  • 23 Apr 2007 Preclinical trials in Rheumatoid arthritis in Portugal (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top